Navigation Links
Personalized medicine has finally arrived -- or has it?
Date:2/26/2014

As the price for decoding a person's DNA keeps dropping, expectations for personalized medicine based on specific genetic profiling rise. But translating an individual's genetic data into finely tailored medical treatments still faces major challenges, explains a new article in Chemical & Engineering News (C&EN), the weekly magazine of the American Chemical Society.

Rick Mullin, senior editor at C&EN, notes that advances in DNA sequencing have allowed researchers to design some therapies, particularly in the cancer realm, for patients with certain genetic traits. As the technology for reading people's genes improves and drops even further in cost, more progress is on the horizon. The U.S. Food and Drug Administration, the government body responsible for approving pharmaceuticals for commercialization, supports these efforts. With the stars seemingly aligned, some industry experts have declared that the age of personalized medicine has arrived. So why do others claim that victory is still a long way off?

The article points out that when pharmaceutical labs launched their search for new drugs based on genomics more than 15 years ago, the focus was almost exclusively on DNA sequences. But now researchers have realized that for personalized medicine to truly take hold, they need to also pay attention to individuals' health histories, their environments and how their genes actually translate into physical traits. This requires a shift in thinking, plus closer ties between the research and clinical sides, and ultimately, insurers. But perhaps the tallest barrier is cultural an attitude among some in the health care industry to simply continue business as usual.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. Second-most common breast cancer subtype may benefit from personalized treatment approach
2. Can personalized tumor vaccines improve interleukin-2 treated metastatic melanoma?
3. How can we improve the efficacy of antipsychotics in the era of personalized pharmacotherapy?
4. A cost-effective way toward personalized cancer drugs
5. Oncogenic signatures mapped in TCGA a guide for the development of personalized therapy
6. "GenoVive is changing the face of personalized health by continuing research efforts with Harvard."
7. Cancer research implies future for personalized medicine, reduction in animal testing
8. Notre Dame researchers develop system that uses a big data approach to personalized healthcare
9. Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market
10. Personalized health care will revolutionize 21st century medicine, says NJIT professor
11. Personalized medicine eliminates need for drug in 2 children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, LLC, ... for the treatment of bacterial infections, today announced ... antibacterial candidates from Pro Bono Bio Ltd (PBB) ... of multi-drug resistant forms of Gram-negative bacteria.   The ... Infectives Ltd, a PBB group company. ...
(Date:1/26/2017)...  Crossmatch, a leading provider of security and identity ... combatting fraud, waste and abuse in assistance operations around ... on Disaster Relief conference in Panama City ... and foreign assistance organizations throughout Latin America ... a largely unacknowledged problem in the foreign assistance and ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... Feb. 16, 2017  Rhythm, a biopharmaceutical ... deficiencies that result in life-threatening metabolic disorders, ... million mezzanine round of financing with existing ... Capital, New Enterprise Associates, Pfizer Venture Investments, ... healthcare investment fund. Rhythm will use the ...
(Date:2/16/2017)... ... February 16, 2017 , ... ... extended its industry leading Biochemistry Services specifically targeting the rapidly growing needs ... methods for the biochemical and biosimilar characterization , product-related impurity characterization, ...
(Date:2/15/2017)... ... February 15, 2017 , ... Park Systems , a leader in Atomic ... software that drastically boosts productivity with single click reliable nanoscale images, is now available ... setting up and taking the image once done manually by the operator producing high ...
(Date:2/15/2017)...  NASA provider SpaceX is scheduled to launch its ... Station  no earlier than 10:01 a.m. EST Saturday, Feb. ... 8:30 a.m. on NASA Television and the agency,s website. ... lift off on the company,s Falcon 9 rocket from ... Center in Florida , ...
Breaking Biology Technology: